Needham & Company LLC Predicts Lower Earnings for Teleflex

Teleflex Incorporated (NYSE:TFX) – Investment analysts at Needham & Company LLC cut their Q4 2025 EPS estimates for shares of Teleflex in a report issued on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now anticipates that the medical technology company will post earnings of $3.65 per share for the quarter, down from their previous estimate of $3.80. Needham & Company LLC has a “Buy” rating and a $138.00 price target on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

A number of other equities research analysts also recently weighed in on TFX. Truist Financial lifted their target price on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a report on Thursday, December 18th. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 target price on shares of Teleflex in a research note on Wednesday, December 17th. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Finally, Wells Fargo & Company reduced their price objective on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $139.00.

Teleflex Price Performance

NYSE:TFX opened at $104.40 on Thursday. The company has a market cap of $4.61 billion, a P/E ratio of -14.20, a P/E/G ratio of 1.38 and a beta of 0.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The firm’s fifty day moving average price is $116.10 and its two-hundred day moving average price is $119.56. Teleflex has a one year low of $100.18 and a one year high of $184.34.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. During the same period last year, the business earned $3.49 earnings per share. The firm’s revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. Teleflex’s dividend payout ratio is presently -18.50%.

Institutional Trading of Teleflex

Hedge funds have recently bought and sold shares of the company. Empowered Funds LLC boosted its stake in shares of Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares during the period. Jane Street Group LLC raised its holdings in Teleflex by 42.6% in the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after acquiring an additional 1,895 shares during the last quarter. State of Alaska Department of Revenue boosted its position in shares of Teleflex by 2.2% during the second quarter. State of Alaska Department of Revenue now owns 26,291 shares of the medical technology company’s stock valued at $3,111,000 after buying an additional 557 shares during the last quarter. KLP Kapitalforvaltning AS boosted its holdings in shares of Teleflex by 4.4% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 9,400 shares of the medical technology company’s stock valued at $1,113,000 after acquiring an additional 400 shares during the last quarter. Finally, Thompson Investment Management Inc. raised its stake in Teleflex by 2.1% during the 2nd quarter. Thompson Investment Management Inc. now owns 4,970 shares of the medical technology company’s stock valued at $588,000 after buying an additional 100 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.